
Bulgaria’s competition regulator said that it gave the green light to Belgium-based KBC Bank, a unit of financial group KBC, to acquire a 100% direct interest in Raiffeisenbank Bulgaria and indirect control of the target company’s wholly-owned units Raiffeisen Leasing Bulgaria, Raiffeisen Asset Management (Bulgaria), Raiffeisen Insurance Broker, and Raiffeisen Service.
Other market participants have larger or similar market positions and are able to exert effective competitive pressure on the merged banking group, the antitrust body added. Austrian Raiffeisenbank Group continues operate subsidiaries in over 30 countries including Japan, the United States, and most of Eastern and Central Europe.
According to the CPC, the planned deal does not have the potential to impact competitiveness and incentives to compete for both the merging companies and their competitors in ways that are unfavourable to consumers. The new merged group will have neither the ability nor incentive to limit effective competition in vertically affected markets, the regulator also said.
In November, the KBC group said that KBC Bank agreed to acquire Raiffeisenbank Bulgaria, comprising the Bulgarian banking operations of Austria-based Raiffeisen Bank International, for 1.015 billion euro ($1.11 billion) in cash.
Bulgaria’s banking system is competitive, with 24 banks in operation including both local organizations and EU subsidiaries. The top 5 banks in Bulgaria accounted for 66% of all operations in 2020.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Fortnite Returns to Apple’s U.S. App Store After Five-Year Ban
May 21, 2025 by
CPI
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas